Nitric oxide and the immune response

被引:2669
作者
Bogdan, C [1 ]
机构
[1] Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany
关键词
D O I
10.1038/ni1001-907
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the past two decades, nitric oxide (NO) has been recognized as one of the most versatile players in the immune system. It is involved in the pathogenesis and control of infectious diseases, tumors, autoimmune processes and chronic degenerative diseases. Because of its variety of reaction partners (DNA, proteins, low-molecular weight thiols, prosthetic groups, reactive oxygen intermediates), its widespread production (by three different NO synthases (NOS) and the fact that its activity is strongly influenced by its concentration, NO continues to surprise and perplex immunologists. Today, there is no simple, uniform picture of the function of NO in the immune system. Protective and toxic effects of NO are frequently seen in parallel. Its striking inter- and intracellular signaling capacity makes it extremely difficult to predict the effect of NOS inhibitors and NO donors, which still hampers therapeutic applications.
引用
收藏
页码:907 / 916
页数:10
相关论文
共 192 条
  • [61] Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection
    Fritsche, G
    Larcher, C
    Schennach, H
    Weiss, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (09) : 1388 - 1394
  • [62] FRUCHT DM, 2001, IN PRESS TRENDS IMMU
  • [63] Furuke K, 1999, J IMMUNOL, V163, P1473
  • [64] Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB
    Ganster, RW
    Taylor, BS
    Shao, LF
    Geller, DA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) : 8638 - 8643
  • [65] Gao JJ, 1999, J IMMUNOL, V163, P4095
  • [66] Gaston B., 2002, NITRIC OXIDE INFECT, P37
  • [67] Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2
    Gilkeson, GS
    Mudgett, JS
    Seldin, MF
    Ruiz, P
    Alexander, AA
    Misukonis, MA
    Pisetsky, DS
    Weinberg, JB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (03) : 365 - 373
  • [68] L-arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis
    Gobert, AP
    Daulouede, S
    Lepoivre, M
    Boucher, JL
    Bouteille, B
    Buguet, A
    Cespuglio, R
    Veyret, B
    Vincendeau, P
    [J]. INFECTION AND IMMUNITY, 2000, 68 (08) : 4653 - 4657
  • [69] Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells
    Gotoh, T
    Mori, M
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 144 (03) : 427 - 434
  • [70] Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease
    Grisham, MB
    Granger, DN
    Lefer, DJ
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (4-5) : 404 - 433